SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 77 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,404,000 | -54.4% | 1,840,587 | +2.8% | 0.00% | – |
| Q3 2016 | $3,080,000 | -3.8% | 1,790,891 | +0.6% | 0.00% | -100.0% |
| Q2 2016 | $3,203,000 | +17.3% | 1,779,542 | +53.8% | 0.00% | – |
| Q1 2016 | $2,731,000 | +3.1% | 1,157,226 | 0.0% | 0.00% | – |
| Q4 2015 | $2,650,000 | +0.9% | 1,157,226 | 0.0% | 0.00% | – |
| Q3 2015 | $2,627,000 | +62.1% | 1,157,226 | +103.4% | 0.00% | – |
| Q2 2015 | $1,621,000 | +104.2% | 568,854 | +56.9% | 0.00% | – |
| Q1 2015 | $794,000 | +2546.7% | 362,465 | +1641.7% | 0.00% | – |
| Q4 2014 | $30,000 | – | 20,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
| MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
| 683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
| Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
| BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
| Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
| Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |